APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome-Reference-Cited by-同舟云学术

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome

Published:2014-01-16 Issue:6 Volume:16 Page:537-544
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

van den Hoek A. M.¹,van der Hoorn J. W. A.¹,Maas A. C.¹,van den Hoogen R. M.¹,van Nieuwkoop A.¹,Droog S.¹,Offerman E. H.¹,Pieterman E. J.¹,Havekes L. M.¹²³,Princen H. M. G.¹

Affiliation:

1. Metabolic Health Research; TNO; Leiden the Netherlands

2. Department of General Internal Medicine, Endocrinology and Metabolic Diseases; Leiden University Medical Center; Leiden the Netherlands

3. Department of Cardiology; Leiden University Medical Center; Leiden The Netherlands

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12252/fullpdf

Reference47 articles.

1. The metabolic syndrome: more than the sum of its parts?;Reilly;Circulation,2003

2. Obesity wars: molecular progress confronts an expanding epidemic;Flier;Cell,2004

3. Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview;Varga;Obes Rev,2010

4. Mouse models of the metabolic syndrome;Kennedy;Dis Model Mech,2010

5. Animal models of insulin resistance and cardiovascular disease: some therapeutic approaches using JCR:LA-cp rat;Brindley;Diabetes Obes Metab,2002

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into metabolic‐associated steatotic liver disease preclinical models;Liver International;2024-01-30

2. Combined GIP receptor and GLP1 receptor agonism attenuates NAFLD in male APOE∗3-Leiden.CETP mice;eBioMedicine;2023-07

3. Intensive cholesterol-lowering treatment reduces synovial inflammation during early collagenase-induced osteoarthritis, but not pathology at end-stage disease in female dyslipidemic E3L.CETP mice;Osteoarthritis and Cartilage;2023-07

4. Proof-of-concept study for liver-directed miQURE technology in a dyslipidemic mouse model;Molecular Therapy - Nucleic Acids;2023-06

5. IL-1β inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model;Osteoarthritis and Cartilage;2023-03